Neurology News

As part of the ongoing challenge to achieve work-life integration, experts are pursuing creative endeavors and practicing decompression to provide outlets for physicians struggling with burnout.

Retirement planning for physicians is a critical aspect of financial management, given the unique challenges and opportunities they face.

Treatment of atrial fibrillation with asundexian, a novel factor XIa inhibitor, was associated with increased stroke and systemic embolism risk despite lower bleeding risk compared with apixaban, a speaker reported.

The first patient has been dosed in a phase 3 clinical trial of oral cladribine for the treatment of generalized myasthenia gravis, according to the manufacturer.

Treatment-limiting decisions were made for almost half of patients with severe traumatic brain injuries, with higher rates in those older in age, according to data.

Clinicians will gather for AIMed24 to meet with industry leaders and innovators and attend keynotes and workshops to discuss the future of AI implementation in medicine, according to information from the meeting organizers.

Sacituzumab govitecan-hziy exhibited efficacy as therapy for two traditionally difficult-to-treat populations, according to results of a window-of-opportunity trial.

Attempts to curtail prior authorizations for patients insured by Medicare Advantage plans have failed in back-to-back legislative sessions in 2019 and 2021, but a new bill has some experts hopeful that the third time is a charm.

Prodromal treatment with 100 mg ubrogepant was associated with greater functionality, fewer activity limitations and a high degree of satisfaction at 24 hours in patients with migraine, according to research published in Neurology.

The FDA has granted fast-track designation to an investigational tau positron emission tomography diagnostic that can be used for a range of neurodegenerative conditions, according to the manufacturer.